Insider Trading History of Stevens David R

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Stevens David R since 2005. This trader's CIK number is 1292382. At the time of last reporting, Stevens David R was the Director of Ampio Pharmaceuticals, Inc.. (stock ticker symbol AMPE). Also see all insider trading activities at Ampio Pharmaceuticals, Inc..

Note that in the past Stevens David R also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Ampio Pharmaceuticals, Inc. (AMPE) by Stevens David R

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2023 AMPE 95,000 $20,800 0 $0 0 $0

Yearly summary of insider trading at Neorx Corp (PARD) by Stevens David R

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2011 PARD 0 $0 0 $0 36,145 $0
2009 PARD 6,450 $22,097 0 $0 0 $0
2008 PARD 7,618 $39,994 0 $0 0 $0
0005 PARD 34,500 $17,664 0 $0 0 $0


Insider trading activities at 2 companies by Stevens David R:

1. Ampio Pharmaceuticals, Inc. (AMPE)

2. Neorx Corp (PARD)

Table 1. Insider trading of Ampio Pharmaceuticals, Inc. (AMPE) by Stevens David R

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2023-05-11 AMPE Buy 50,000 .22 10,900
2023-05-12 AMPE Buy 45,000 .22 9,900

Table 2. Insider trading of Neorx Corp (PARD) by Stevens David R

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2011-06-09 PARD Option Ex 36,145 .00 0
2009-01-09 PARD Buy 6,450 3.43 22,097
2008-01-15 PARD Buy 7,618 5.25 39,994
0005-05-18 NERX Buy 34,500 .51 17,664

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Stevens David R (Director of Ampio Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.